Tokyo, April 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061332) titled 'Different treatment efficiency for Transient Ischemic Attack' on April 21.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - Transient Ischemic Attack
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify different treatment for the prevention of secondary stroke after TIA
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - they were at least 18 years of age with a noncardioembolic ischemic stroke or high-risk TIA within 72 hours after the onset of symptoms and there was a plan for treatment with dual or single antiplatelet therapy.
Key exclusion criteria - Patients with ischemic stroke had a maximum score of over 15 on the National Institutes of Health Stroke Scale
Target Size - 500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 21 Day
Anticipated trial start date - 2026 Year 04 Month 21 Day
Last follow-up date - 2027 Year 04 Month 21 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070177
Disclaimer: Curated by HT Syndication.
